SEC 13F Intelligence

Acadian Asset Management LLC / GSK

Acadian Asset Management LLC’s Gsk PLC Position

Does Acadian Asset Management LLC own Gsk PLC (GSK)? Yes11.80M shares worth $651M (+0.92% of its 13F portfolio) as of Q1 2026, up from 8.96M shares the prior filed quarter.

Position Value
$651M
Q1 2026
Shares
11.80M
% of Portfolio
+0.92%
Quarters Held
15
currently held

Position History GSK

Reported value by quarter
Q3 ’22: $192MQ3 ’22Q4 ’22: $230MQ1 ’23: $176MQ1 ’23Q2 ’23: $150MQ3 ’23: $49MQ3 ’23Q4 ’23: $29MQ1 ’24: $95MQ1 ’24Q2 ’24: $66MQ3 ’24: $166MQ3 ’24Q4 ’24: $45MQ1 ’25: $154MQ1 ’25Q2 ’25: $108MQ3 ’25: $120MQ3 ’25Q4 ’25: $440MQ1 ’26: $651MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202611.80M$651M+0.92%
Q4 20258.96M$440M+0.72%
Q3 20252.79M$120M+0.21%
Q2 20252.82M$108M+0.22%
Q1 20253.98M$154M+0.44%
Q4 20241.32M$45M+0.13%
Q3 20244.07M$166M+0.52%
Q2 20241.71M$66M+0.20%
Q1 20242.22M$95M+0.33%
Q4 2023792.9K$29M+0.11%
Q3 20231.34M$49M+0.20%
Q2 20234.21M$150M+0.62%
Q1 20234.94M$176M+0.77%
Q4 20226.56M$230M+1.13%
Q3 20226.51M$192M+1.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Acadian Asset Management LLC’s full portfolio or all institutional holders of GSK.